 Holly Wyatt
Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Loss | 50 | 2025 | 740 | 4.600 |
Why?
| | Obesity | 62 | 2025 | 2885 | 3.570 |
Why?
| | Overweight | 15 | 2025 | 531 | 1.610 |
Why?
| | Exercise | 24 | 2024 | 1934 | 1.580 |
Why?
| | Motor Activity | 13 | 2014 | 684 | 1.370 |
Why?
| | Energy Intake | 17 | 2023 | 462 | 1.180 |
Why?
| | Diet, Fat-Restricted | 12 | 2018 | 80 | 1.140 |
Why?
| | Diet, Carbohydrate-Restricted | 9 | 2024 | 32 | 1.030 |
Why?
| | Behavior Therapy | 6 | 2019 | 241 | 0.890 |
Why?
| | Health Promotion | 7 | 2013 | 718 | 0.890 |
Why?
| | Body Weight | 10 | 2019 | 947 | 0.830 |
Why?
| | Weight Gain | 17 | 2013 | 510 | 0.770 |
Why?
| | Health Behavior | 9 | 2018 | 743 | 0.710 |
Why?
| | Energy Metabolism | 11 | 2019 | 875 | 0.680 |
Why?
| | Life Style | 14 | 2023 | 462 | 0.680 |
Why?
| | Diet | 12 | 2024 | 1212 | 0.650 |
Why?
| | Monitoring, Ambulatory | 4 | 2010 | 83 | 0.640 |
Why?
| | Body Mass Index | 25 | 2025 | 2274 | 0.590 |
Why?
| | Weight Reduction Programs | 6 | 2019 | 110 | 0.590 |
Why?
| | Registries | 9 | 2022 | 1903 | 0.530 |
Why?
| | Mental Health | 1 | 2022 | 691 | 0.490 |
Why?
| | Risk Reduction Behavior | 2 | 2015 | 209 | 0.490 |
Why?
| | Cardiovascular Diseases | 8 | 2023 | 2008 | 0.480 |
Why?
| | Television | 2 | 2013 | 74 | 0.450 |
Why?
| | Diet, Reducing | 7 | 2018 | 87 | 0.430 |
Why?
| | Middle Aged | 49 | 2025 | 31177 | 0.430 |
Why?
| | Dietary Proteins | 3 | 2023 | 129 | 0.420 |
Why?
| | Feeding Behavior | 6 | 2013 | 626 | 0.420 |
Why?
| | Internet | 4 | 2023 | 620 | 0.410 |
Why?
| | Survivors | 2 | 2016 | 464 | 0.400 |
Why?
| | Adult | 50 | 2025 | 35634 | 0.400 |
Why?
| | Endocrinology | 1 | 2013 | 74 | 0.380 |
Why?
| | Walking | 7 | 2011 | 500 | 0.380 |
Why?
| | Humans | 82 | 2025 | 129847 | 0.370 |
Why?
| | Cause of Death | 1 | 2013 | 395 | 0.370 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2023 | 2444 | 0.350 |
Why?
| | Female | 57 | 2025 | 68829 | 0.330 |
Why?
| | Male | 56 | 2025 | 63759 | 0.320 |
Why?
| | Thinness | 1 | 2009 | 89 | 0.310 |
Why?
| | Dietary Carbohydrates | 5 | 2024 | 152 | 0.310 |
Why?
| | Breast Neoplasms | 3 | 2016 | 2104 | 0.300 |
Why?
| | Disease Outbreaks | 2 | 2009 | 349 | 0.300 |
Why?
| | Dietary Fats | 5 | 2013 | 303 | 0.300 |
Why?
| | Dairy Products | 1 | 2008 | 36 | 0.280 |
Why?
| | Community Participation | 1 | 2008 | 125 | 0.260 |
Why?
| | Anti-Obesity Agents | 3 | 2013 | 53 | 0.250 |
Why?
| | Beverages | 3 | 2015 | 68 | 0.250 |
Why?
| | Waist Circumference | 2 | 2024 | 138 | 0.240 |
Why?
| | Non-Nutritive Sweeteners | 2 | 2015 | 5 | 0.240 |
Why?
| | Dietetics | 1 | 2005 | 22 | 0.240 |
Why?
| | Social Support | 2 | 2024 | 587 | 0.230 |
Why?
| | Hormones | 2 | 2009 | 140 | 0.230 |
Why?
| | Basal Metabolism | 2 | 2018 | 58 | 0.230 |
Why?
| | Kidney | 1 | 2012 | 1383 | 0.230 |
Why?
| | Appetite Depressants | 1 | 2004 | 18 | 0.220 |
Why?
| | Exercise Therapy | 3 | 2012 | 413 | 0.210 |
Why?
| | Blood Glucose | 3 | 2024 | 2103 | 0.210 |
Why?
| | Spouses | 1 | 2024 | 103 | 0.210 |
Why?
| | Primary Prevention | 1 | 2005 | 190 | 0.210 |
Why?
| | Health Status | 4 | 2022 | 758 | 0.210 |
Why?
| | United States | 16 | 2015 | 13913 | 0.200 |
Why?
| | Prevalence | 10 | 2014 | 2564 | 0.200 |
Why?
| | Time Factors | 8 | 2019 | 6550 | 0.190 |
Why?
| | Adiposity | 4 | 2023 | 504 | 0.190 |
Why?
| | Blood Pressure | 4 | 2024 | 1736 | 0.190 |
Why?
| | Patient Satisfaction | 3 | 2018 | 639 | 0.190 |
Why?
| | Counseling | 3 | 2015 | 386 | 0.190 |
Why?
| | Washington | 1 | 2022 | 149 | 0.190 |
Why?
| | DNA Repair | 1 | 2003 | 210 | 0.180 |
Why?
| | Biology | 1 | 2022 | 85 | 0.180 |
Why?
| | Aged | 20 | 2024 | 22107 | 0.170 |
Why?
| | Telomere | 1 | 2003 | 232 | 0.170 |
Why?
| | Food | 1 | 2002 | 156 | 0.170 |
Why?
| | Risk Factors | 13 | 2015 | 9801 | 0.170 |
Why?
| | Physical Exertion | 3 | 2011 | 210 | 0.170 |
Why?
| | Quality of Life | 6 | 2021 | 2695 | 0.170 |
Why?
| | Cancer Survivors | 1 | 2024 | 257 | 0.170 |
Why?
| | Contraceptive Agents | 1 | 2020 | 65 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 1 | 2003 | 530 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2018 | 16 | 0.150 |
Why?
| | Diet, High-Protein | 1 | 2018 | 1 | 0.150 |
Why?
| | Rest | 1 | 2018 | 120 | 0.140 |
Why?
| | Self Report | 2 | 2013 | 800 | 0.140 |
Why?
| | Histones | 1 | 2003 | 588 | 0.140 |
Why?
| | Hydrogels | 1 | 2025 | 646 | 0.140 |
Why?
| | Meat | 1 | 2018 | 93 | 0.140 |
Why?
| | Comorbidity | 4 | 2016 | 1551 | 0.140 |
Why?
| | Self-Control | 1 | 2018 | 55 | 0.140 |
Why?
| | Fasting | 1 | 2018 | 268 | 0.130 |
Why?
| | Treatment Outcome | 10 | 2025 | 10241 | 0.130 |
Why?
| | Health Surveys | 6 | 2008 | 495 | 0.130 |
Why?
| | Parent-Child Relations | 2 | 2011 | 259 | 0.130 |
Why?
| | Caloric Restriction | 3 | 2014 | 111 | 0.130 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 521 | 0.130 |
Why?
| | Models, Psychological | 1 | 2018 | 308 | 0.130 |
Why?
| | Eating | 3 | 2013 | 372 | 0.120 |
Why?
| | Prospective Studies | 8 | 2025 | 7158 | 0.120 |
Why?
| | Food Preferences | 2 | 2018 | 116 | 0.120 |
Why?
| | Edible Grain | 2 | 2006 | 48 | 0.110 |
Why?
| | Sweetening Agents | 1 | 2014 | 41 | 0.110 |
Why?
| | Metabolic Syndrome | 2 | 2007 | 340 | 0.110 |
Why?
| | Executive Function | 1 | 2018 | 433 | 0.100 |
Why?
| | Bupropion | 1 | 2013 | 40 | 0.100 |
Why?
| | Drinking Water | 1 | 2014 | 76 | 0.100 |
Why?
| | Recurrence | 2 | 2013 | 1013 | 0.100 |
Why?
| | Nutritional Status | 1 | 2015 | 328 | 0.100 |
Why?
| | Adolescent | 13 | 2019 | 20451 | 0.100 |
Why?
| | Endothelium | 1 | 2013 | 121 | 0.100 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 61 | 0.100 |
Why?
| | Water | 1 | 2015 | 442 | 0.100 |
Why?
| | Naltrexone | 1 | 2013 | 87 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2014 | 260 | 0.100 |
Why?
| | Primary Health Care | 1 | 2002 | 1687 | 0.100 |
Why?
| | Accelerometry | 1 | 2013 | 93 | 0.090 |
Why?
| | Kidney Function Tests | 1 | 2012 | 152 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 28 | 0.090 |
Why?
| | Insulin | 3 | 2018 | 2330 | 0.090 |
Why?
| | Appetite | 1 | 2011 | 61 | 0.090 |
Why?
| | Body Composition | 3 | 2023 | 649 | 0.090 |
Why?
| | Epidemics | 1 | 2011 | 82 | 0.090 |
Why?
| | Neoplasms | 2 | 2024 | 2454 | 0.080 |
Why?
| | Bariatric Surgery | 1 | 2013 | 197 | 0.080 |
Why?
| | Adipose Tissue | 2 | 2011 | 594 | 0.080 |
Why?
| | Family Health | 2 | 2007 | 198 | 0.080 |
Why?
| | Secondary Prevention | 1 | 2010 | 220 | 0.080 |
Why?
| | Nutritional Requirements | 1 | 2009 | 77 | 0.080 |
Why?
| | Young Adult | 7 | 2019 | 12467 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 160 | 0.080 |
Why?
| | Hypercholesterolemia | 1 | 2010 | 102 | 0.080 |
Why?
| | Public Health | 2 | 2011 | 487 | 0.080 |
Why?
| | Family | 1 | 2013 | 646 | 0.070 |
Why?
| | Cattle | 2 | 2023 | 978 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2009 | 196 | 0.070 |
Why?
| | Aged, 80 and over | 6 | 2009 | 7066 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2011 | 1214 | 0.070 |
Why?
| | Lythraceae | 1 | 2007 | 2 | 0.070 |
Why?
| | Animals | 8 | 2023 | 35409 | 0.070 |
Why?
| | Hydrolyzable Tannins | 1 | 2007 | 5 | 0.070 |
Why?
| | Sick Leave | 1 | 2007 | 11 | 0.070 |
Why?
| | New York | 1 | 2008 | 128 | 0.070 |
Why?
| | Coronary Disease | 2 | 2007 | 385 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2009 | 334 | 0.070 |
Why?
| | Dietary Sucrose | 1 | 2007 | 48 | 0.070 |
Why?
| | Patient Compliance | 2 | 2018 | 568 | 0.070 |
Why?
| | Efficiency | 1 | 2007 | 92 | 0.070 |
Why?
| | Child | 7 | 2013 | 20962 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 957 | 0.070 |
Why?
| | Triglycerides | 4 | 2013 | 528 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1284 | 0.070 |
Why?
| | Cholesterol, LDL | 2 | 2024 | 358 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2019 | 3384 | 0.070 |
Why?
| | Regression Analysis | 2 | 2007 | 998 | 0.060 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 529 | 0.060 |
Why?
| | Interviews as Topic | 2 | 2007 | 709 | 0.060 |
Why?
| | Metabolic Diseases | 1 | 2007 | 104 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2007 | 743 | 0.060 |
Why?
| | Coronary Artery Bypass | 1 | 2007 | 224 | 0.060 |
Why?
| | Cost of Illness | 1 | 2007 | 277 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 1877 | 0.060 |
Why?
| | Calorimetry, Indirect | 2 | 2018 | 81 | 0.060 |
Why?
| | Physical Fitness | 1 | 2007 | 203 | 0.060 |
Why?
| | Cross-Sectional Studies | 5 | 2014 | 5085 | 0.060 |
Why?
| | Marital Status | 1 | 2005 | 44 | 0.060 |
Why?
| | Capsules | 1 | 2025 | 42 | 0.060 |
Why?
| | Analysis of Variance | 4 | 2011 | 1291 | 0.060 |
Why?
| | Health Care Costs | 1 | 2007 | 367 | 0.060 |
Why?
| | Heart Ventricles | 1 | 2009 | 781 | 0.060 |
Why?
| | Computer Simulation | 1 | 2009 | 941 | 0.060 |
Why?
| | Colorado | 4 | 2007 | 4410 | 0.060 |
Why?
| | Cyclobutanes | 1 | 2004 | 6 | 0.050 |
Why?
| | Patient Participation | 1 | 2007 | 414 | 0.050 |
Why?
| | Rural Population | 1 | 2008 | 521 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 103 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2005 | 224 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2024 | 284 | 0.050 |
Why?
| | Rats, Wistar | 3 | 2011 | 443 | 0.050 |
Why?
| | Lactones | 1 | 2004 | 55 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2007 | 532 | 0.050 |
Why?
| | Program Evaluation | 1 | 2007 | 878 | 0.050 |
Why?
| | Diabetic Angiopathies | 1 | 2005 | 261 | 0.050 |
Why?
| | Lipoproteins | 3 | 2010 | 172 | 0.050 |
Why?
| | Body Constitution | 1 | 2002 | 53 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 787 | 0.050 |
Why?
| | Acetylation | 1 | 2003 | 244 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 822 | 0.050 |
Why?
| | Leisure Activities | 1 | 2002 | 29 | 0.050 |
Why?
| | Bleomycin | 1 | 2003 | 243 | 0.050 |
Why?
| | Educational Status | 3 | 2012 | 474 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1368 | 0.050 |
Why?
| | Fruit | 1 | 2002 | 131 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 377 | 0.040 |
Why?
| | DNA Damage | 1 | 2003 | 383 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4896 | 0.040 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 49 | 0.040 |
Why?
| | Telemedicine | 1 | 2007 | 792 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2002 | 509 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 26 | 0.040 |
Why?
| | Phosphorylation | 1 | 2003 | 1716 | 0.040 |
Why?
| | Parents | 1 | 2007 | 1319 | 0.040 |
Why?
| | Cluster Analysis | 2 | 2012 | 483 | 0.040 |
Why?
| | Leptin | 2 | 2013 | 222 | 0.040 |
Why?
| | Portion Size | 1 | 2018 | 6 | 0.040 |
Why?
| | Child, Preschool | 2 | 2011 | 10522 | 0.040 |
Why?
| | Thermogenesis | 1 | 2018 | 44 | 0.040 |
Why?
| | Hunger | 1 | 2018 | 42 | 0.040 |
Why?
| | Craving | 1 | 2018 | 40 | 0.040 |
Why?
| | Motivation | 1 | 2002 | 548 | 0.040 |
Why?
| | Patient Dropouts | 1 | 2018 | 64 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2019 | 179 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 569 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 3161 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1274 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2724 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 1003 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1201 | 0.030 |
Why?
| | Models, Biological | 2 | 2018 | 1724 | 0.030 |
Why?
| | Rats | 3 | 2011 | 5487 | 0.030 |
Why?
| | Lipid Metabolism | 2 | 2011 | 503 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2012 | 5437 | 0.030 |
Why?
| | Precision Medicine | 1 | 2018 | 385 | 0.030 |
Why?
| | Circadian Rhythm | 2 | 2009 | 416 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2024 | 14553 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1951 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 55 | 0.030 |
Why?
| | Nausea | 1 | 2013 | 111 | 0.020 |
Why?
| | Psychotherapy, Group | 1 | 2012 | 65 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2013 | 174 | 0.020 |
Why?
| | Brachial Artery | 1 | 2013 | 192 | 0.020 |
Why?
| | Hypertension | 2 | 2013 | 1242 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 164 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 177 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 647 | 0.020 |
Why?
| | Switzerland | 1 | 2010 | 36 | 0.020 |
Why?
| | Ketone Bodies | 1 | 2010 | 15 | 0.020 |
Why?
| | Japan | 1 | 2010 | 98 | 0.020 |
Why?
| | Behavior, Addictive | 1 | 2011 | 81 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1042 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2011 | 4077 | 0.020 |
Why?
| | Tunica Media | 1 | 2009 | 38 | 0.020 |
Why?
| | Social Environment | 1 | 2011 | 293 | 0.020 |
Why?
| | Australia | 1 | 2010 | 243 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 476 | 0.020 |
Why?
| | Tunica Intima | 1 | 2009 | 84 | 0.020 |
Why?
| | Diastole | 1 | 2009 | 148 | 0.020 |
Why?
| | Systole | 1 | 2009 | 191 | 0.020 |
Why?
| | Photoperiod | 1 | 2009 | 46 | 0.020 |
Why?
| | Socioenvironmental Therapy | 1 | 2009 | 1 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 205 | 0.020 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 127 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2013 | 739 | 0.020 |
Why?
| | Attitude to Health | 1 | 2012 | 433 | 0.020 |
Why?
| | Satiety Response | 1 | 2008 | 9 | 0.020 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2007 | 31 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2007 | 32 | 0.020 |
Why?
| | Adipocytes | 1 | 2009 | 205 | 0.020 |
Why?
| | Polyphenols | 1 | 2007 | 18 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1031 | 0.020 |
Why?
| | Flavonoids | 1 | 2007 | 76 | 0.020 |
Why?
| | Ventricular Remodeling | 1 | 2009 | 256 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3971 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2007 | 127 | 0.020 |
Why?
| | Phenols | 1 | 2007 | 96 | 0.020 |
Why?
| | Echocardiography | 1 | 2009 | 636 | 0.020 |
Why?
| | Demography | 1 | 2007 | 279 | 0.020 |
Why?
| | Bone Density | 1 | 2010 | 463 | 0.020 |
Why?
| | Exercise Test | 1 | 2009 | 614 | 0.020 |
Why?
| | Health Expenditures | 1 | 2007 | 180 | 0.020 |
Why?
| | Nutrition Assessment | 1 | 2006 | 86 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 62 | 0.020 |
Why?
| | Employment | 1 | 2007 | 167 | 0.020 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2006 | 104 | 0.020 |
Why?
| | Homeostasis | 1 | 2009 | 605 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2008 | 521 | 0.020 |
Why?
| | Insurance, Health | 1 | 2007 | 269 | 0.020 |
Why?
| | Interpersonal Relations | 1 | 2009 | 395 | 0.010 |
Why?
| | Sex Factors | 1 | 2011 | 1973 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 558 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1501 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3089 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2016 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2545 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1644 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 944 | 0.010 |
Why?
| | Pediatrics | 1 | 2007 | 1074 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 1003 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2007 | 2481 | 0.010 |
Why?
|
|
Wyatt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|